Survival rates improving for many Americans with a variety of cancers
the ONA take:
According to a new report published in the journal JAMA Oncology, researchers from the Cancer Epidemiology Research Program at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, have found that survival rates are improving for many people with breast, colon, liver, lung, and prostate cancer.
Survival rates are particularly improving for those diagnosed at younger ages. The researchers also observed differences in survival based on race.
Specifically, blacks had poorer survival compared with whites. Of note, results showed black women with ovarian cancer experienced an increase in risk of death over the last 20 years.
In addition, many patients aged 50 to 64 with breast, colorectal, liver, or prostate cancer had significantly increased odds of survival, but patients aged 75 to 85 with the same cancers had smaller decreases in risk of death.
For the study, researchers analyzed data on over 1 million patients diagnosed with breast, colorectal, liver, lung, ovarian, pancreatic, or prostate cancer between 1990 and 2009 from the U.S. National Cancer Institute Surveillance, Epidemiology and End Results (SEER) study.
A cancer false alarm may give false sense of security
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|